AG
ELV icon

Ascent Group’s Elevance Health ELV Stock Holding History

Ascent Group’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$433K Sell
1,478
-1,710
-54% -$562K 0.02% 531
2025
Q4 		$1.12M Sell
3,188
-188
-6% -$63.5K 0.04% 345
2025
Q3 		$1.09M Sell
3,376
-1,891
-36% -$588K 0.04% 346
2025
Q2 		$2.05M Sell
5,267
-1,492
-22% -$600K 0.08% 212
2025
Q1 		$2.94M Buy
6,759
+501
+8% +$201K 0.13% 174
2024
Q4 		$2.31M Buy
6,258
+102
+2% +$42.7K 0.17% 149
2024
Q3 		$3.2M Buy
6,156
+1,253
+26% +$669K 0.24% 100
2024
Q2 		$2.66M Buy
4,903
+1,138
+30% +$602K 0.22% 120
2024
Q1 		$1.95M Buy
3,765
+2,849
+311% +$1.42M 0.17% 178
2023
Q4 		$463K Sell
916
-18
-2% -$8.32K 0.04% 359
2023
Q3 		$423K Sell
934
-22
-2% -$9.98K 0.05% 341
2023
Q2 		$442K Sell
956
-210
-18% -$96.9K 0.05% 322
2023
Q1 		$536K Sell
1,166
-312
-21% -$148K 0.06% 305
2022
Q4 		$758K Sell
1,478
-25
-2% -$12.7K 0.09% 248
2022
Q3 		$822K Buy
1,503
+734
+95% +$351K 0.1% 228
2022
Q2 		$367K Buy
769
+181
+31% +$89.5K 0.04% 354
2022
Q1 		$289K Buy
+588
New +$269K 0.03% 393

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Ascent Group's ELV Position: Q1 2026 in Review

Ascent Group reduced its Elevance Health (ELV) stake by 54% in Q1 2026, selling an estimated $562K and leaving 1,478 shares worth $433K. The position accounts for 0.02% of the portfolio, ranked #531.

Ascent Group first reported a position in ELV in Q1 2022 and has held it in 17 quarters since. The position peaked at $3.2M in Q3 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Ascent Group held 1,478 shares of Elevance Health worth $433K as of Q1 2026.
  • Ascent Group sold 1,710 Elevance Health shares in Q1 2026, an estimated $562K.
  • Elevance Health made up 0.02% of Ascent Group's portfolio in Q1 2026, its #531 holding.
  • Ascent Group first reported a position in Elevance Health in Q1 2022 and has held it in 17 quarters since.
  • Ascent Group's Elevance Health position peaked at $3.2M in Q3 2024.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Ascent Group's 13F filing for Q1 2026, filed 15 May 2026.